Assessment of faithful interleukin-3 production by novel bicistronic interleukin-3 reporter mice
Introduction
The cytokine interleukin-3 (IL-3) is well documented at promoting the in vitro differentiation and proliferation of murine hematopoietic progenitor cells and the survival and activation of mature myeloid cells, including mast cells, basophils, dentritic cells, neutrophils, eosinophils, macrophages, and erythrocytes [[1], [2], [3]]. A role for IL-3 in allergic inflammation is suggested by the ability of IL-3 to promote basophil and mast cell growth, differentiation, and mediator release [[4], [5], [6], [7], [8]]. In addition, IL-3 has been reported to enhance monocyte/macrophage activation and/or phagocytosis [[9], [10], [11]], promote the secretory function of eosinophils [12], stimulate endothelial cell proliferation, migration, and activation [13], modulate development of regulatory T (Treg) cells [14], and enhance the development and function of classical and plasmacytoid dendritic cells [15,16].
Despite the activities attributed to IL-3, mice lacking the IL-3 gene display intact steady-state hematopoiesis, including having normal numbers of tissue mast cells and basophils [17,18]. These findings, and the fact that IL-3 levels in the blood or tissues are low or undetectable in normal mice, suggest that IL-3 either is not involved in hematopoietic cell development under physiological conditions or is a component of a larger network of redundant cytokines. On the other hand, our experiments with IL-3 gene-deficient (knockout [KO]) mice have revealed either a net suppressive or stimulatory role for IL-3 during certain disease conditions. For example, we have shown that IL-3 KO mice show impaired T cell-dependent contact hypersensitivity responses to haptens [17], have an increased accumulation of eosinophils during ragweed-induced allergic peritonitis [19], mount attenuated mast cell and basophil responses to gastrointestinal nematode infection that result in compromised worm expulsion [7,18,20,21], and are more resistant to blood-stage malaria infection [22]. More recently, it has been reported that IL-3 deficiency protects mice against sepsis by reducing myeloid cell proinflammatory cytokine production, and that elevated levels of IL-3 correlate with increased mortality in human septic patients [1].
The main sources of IL-3 are activated T helper (Th) cells [23]. While the particular subsets of Th cells that produce IL-3 are not well defined, both Th1 and Th2 are known to secrete IL-3 [24]; Our results with Plasmodium-infected mice [22] and with contact hypersensitivity responses in mice [17] suggest that non-CD4 T cells may also represent a biologically significant source of IL-3 in vivo. Indeed, other cell types have been reported to express IL-3 such as mast cells [25,26], basophils [27], NKT cells [28], eosinophils [29], endothelial cells [30], innate response activator (IRA) B cells [1], and neurons and astrocytes in the brain [31].
The fact that many different cell types represent potential sources of IL-3 in vivo raises many important questions: (1) Does the nature, strength, site and stage of infection determine the type of cellular sources of IL-3? (2) Does the type of IL-3-producing cells determine the nature, quality, duration and outcome of the immune responses? (3) What are the molecular mechanisms underlying the expression of IL-3, and are these mechanisms cell-type and/or tissue-specific? The investigation of such questions requires faithful identification and characterization of IL-3-producing cells in vivo. Unfortunately, the problems inherent in existing methods for detecting the temporal and cell-type-specific patterns of IL-3 expression make answering these questions difficult or unfeasible. To overcome these problems, we have used a CRISPR/Cas approach to engineer mice containing a bicistronic mRNA linking a readily identifiable reporter, enhanced green fluorescent protein (ZsGreen1), to IL-3 expression. We characterize these IL-3-ZsGreen1 reporter (3Gr) mice using both in vitro T cell assays and in vivo infection with Nippostrongylus brasiliensis (N.b.). These novel reporter mice represent a valuable resource to examine the potential and known involvement of IL-3 in various disease models.
Section snippets
Mice
Male and female C57BL/6 J mice (The Jackson Laboratory, Bar Harbor, ME) were used to generate 3Gr and corresponding wild-type (WT) control mice. Heterozygous 3Gr mice on a C57BL/6 background were generated and provided by the University of North Carolina Animal Models Core Facility. For in vitro studies, we used pooled cells obtained from 7 to 12 week old male and female 3Gr and WT mice. For in vivo experiments, we used age-matched male 3Gr and WT mice that were 7–12 weeks of age at the
Generation of 3Gr mice
It has been difficult to determine the temporal, tissue, and cell-type specific patterns of IL-3 production in vivo. This difficulty arises from the fact that IL-3, like many cytokines, has a short in vivo half-life and does not normally accumulate to detectable levels as measured in serum samples. Analysis of IL-3 production in vivo has primarily been extrapolated from studies that rely on the ex vivo re-stimulation of isolated cells, measurement of IL-3 mRNA accumulation by cells in vivo, and
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
The authors would like to thank Joseph Urban for Nippostrongylous brasiliensis and Dale Cowley for assistance in the design and generation of reporter mice. This work was supported by Public Health Service grantAI094443 from the National Institute of Allergy and Infectious Diseases.
References (41)
- et al.
Regulation of mast cell development by inflammatory factors
Curr. Med. Chem.
(2007) - et al.
Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: use of interleukin-3
Exp. Hematol.
(2012) - et al.
Involvement of Interleukin-3 in delayed-type hypersensitivity
Blood
(1998) - et al.
GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation
Immunity
(2019) - et al.
Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis
Science
(2015) - et al.
The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling
Immunol. Rev.
(2012) - et al.
Mast cell growth, differentiation, and death
Clin. Rev. Allergy Immunol.
(2002) Basophil modulation by cytokine instruction
Eur. J. Immunol.
(2012)- et al.
IL-3 is required for increases in blood basophils in nematode infection in mice and can enhance IgE-dependent IL-4 production by basophils in vitro
Lab. Invest.
(2008)
Basophil in immunity
Annu. Rev. Immunol.
Interleukin-3 administration enhances human monocyte function in vivo
Br. J. Haematol.
Regulation of macrophage activation by IL-3. II. IL-3 and lipopolysaccharide act synergistically in the regulation of IL-1 expression
J. Immunol.
Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis
J. Exp. Med.
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3
J. Clin. Invest.
Human IL-3 stimulates endothelial cell motility and promotes in vivo new vessel formation
J. Immunol.
IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3+ regulatory T cells
J. Immunol.
IL-3 in dendritic cell development and function: a comparison with GM-CSF and IL-4
Immunobiology
Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites
Nature
Absence of interleukin-3 does not affect the severity of local and systemic anaphylaxis but does enhance eosinophil infiltration in a mouse model of allergic peritonitis
Immunol. Lett.
Cited by (2)
Role and mechanism of interleukin-3 in bone metabolism
2022, Chinese Journal of Tissue Engineering Research